About the company

The goal of establishing HRA Pharma in 1998 was to provide therapeutic solutions for medical needs that large pharmaceutical concerns had not provided until then. Almost twenty years later, reality has surpassed our dreams. As pioneers in the field of women’s health, we have become the leading manufacturer of emergency hormonal contraception in Europe. Our women’s health franchise, including innovative and value-added products and ambitious projects in development, is the main driver of HRA Pharma’s future growth.

Twenty years since our humble beginnings, HRA Pharma has become an innovative, fast-growing, pharmacy-focused company with multiple awards, operational presence in 11 European countries, and partnerships that have expanded product availability to over 90 countries worldwide.

As experts in the treatment of rare diseases, we have created a portfolio of three key endocrinological therapeutic drugs, the development of which is accelerated in Europe.

These outstanding results are thanks to the passion and dedication of our teams. They are a testament to the breadth and depth of our expertise and the success of these teams. “In the future, we intend to become one of the fastest growing companies in the field of “Consumer Healthcare”, while at the same time building on our strengths for the benefit of our customers. We develop new products and identify new opportunities that match our unique capabilities. Backed by supportive shareholders, we have the resources to pursue a growth strategy and capitalize on investment opportunities when we discover them.”